From fabric to tissue: Recovered wool keratin/polyvinylpyrrolidone biocomposite fibers as artificial scaffold platform.

Biocomposite fibers Polyvinylpyrrolidone Waste reuse Wool keratin Wound healing

Journal

Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 17 11 2019
revised: 14 05 2020
accepted: 01 06 2020
entrez: 19 8 2020
pubmed: 19 8 2020
medline: 27 4 2021
Statut: ppublish

Résumé

Keratin extracted from wool fibers has recently gained attention as an abundant source of renewable, biocompatible material for tissue engineering and drug delivery applications. However, keratin extraction and processing generally require a copious use of chemicals, not only bearing consequences for the environment but also possibly compromising the envisioned biological outcome. In this study, we present, for the first time, keratin-PVP biocomposite fibers obtained via an all-water co-electrospinning process and explored their properties modulation as a result of different thermal crosslinking treatments. The protein-based fibers featured homogenous morphologies and average diameters in the range of 170-290 nm. The thermomechanical stability and response to a wet environment can be tuned by acting on the curing time; this can be achieved without affecting the 3D fibrous network nor the intrinsic hydrophilic behavior of the material. More interestingly, our protein-based membranes treated at 170 °C for 18 h successfully sustained the attachment and growth of primary human dermal fibroblasts, a cellular model which can recapitulate more faithfully the physiological human tissue conditions. Our proposed approach can be viewed as pivotal in designing tunable protein-based scaffolds for the next generation of skin tissue growth devices.

Identifiants

pubmed: 32806258
pii: S0928-4931(19)34305-X
doi: 10.1016/j.msec.2020.111151
pii:
doi:

Substances chimiques

Keratins 68238-35-7
Povidone FZ989GH94E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111151

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Giulia Suarato (G)

Smart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy; Translational Pharmacology, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy. Electronic address: giulia.suarato@iit.it.

Marco Contardi (M)

Smart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.

Giovanni Perotto (G)

Smart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.

Jose' A Heredia-Guerrero (JA)

Smart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy; IHSM La Mayora, Departamento de Mejora Genética y Biotecnología, Consejo Superior de Investigaciones Científicas, E-29750 Algarrobo-Costa, Málaga, Spain.

Fabrizio Fiorentini (F)

Smart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.

Luca Ceseracciu (L)

Materials Characterization Facility, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.

Cataldo Pignatelli (C)

Smart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.

Doriana Debellis (D)

Electron Microscopy Facility, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.

Rosalia Bertorelli (R)

Translational Pharmacology, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.

Athanassia Athanassiou (A)

Smart Materials, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH